In recent weeks, two prominent men, Britain’s King Charles and Defense Secretary Lloyd Austin, revealed they were dealing with prostate issues. CBS News chief medical correspondent Dr. Jon LaPook offers us a prostate “user’s guide,” and explains PSA tests and the process of diagnosing and treating ailments such as benign prostatic hyperplasia and prostate cancer. Source
Author Archives: Stonecom Interactive
Sharon Stone, artist
The Oscar-nominated actress and activist has returned to her love of painting; this past year she’s had two gallery shows in the U.S., with a third about to open in Berlin. Source
Capturing art left behind in a whiskey glass
Photographer Ernie Button, a whiskey fan, discovered that the dried remains of single malt scotch in the bottom of a glass can offer unique and tantalizing patterns, even evoking alien worlds. Source
Bishop Gene Robinson on why “God called me out of the closet”
In 2003 the Episcopal Church consecrated Robinson as the first openly-gay bishop in all of Christendom. Death threats followed, but so did a shift in the relationship between the LGBTQ community and the church. Source
Bishop Gene Robinson: “God called me out of the closet”
In 2003 he became the first openly gay bishop in all of Christendom, when the Episcopal Church consecrated Gene Robinson the 9th bishop of New Hampshire. Death threats followed, but so did a shift in the relationship between the LGBTQ community and the church. “Sunday Morning” senior contributor Ted Koppel talks with Bishop Robinson about his quest to live an authentic life; and with other gay bishops serving today whom Robinson calls his legacy. Source
Emma Stone and director Yorgos Lanthimos on “Poor Things”
The Oscar-winning star of “La La Land,” and the director of “The Favourite” have teamed up on several projects; their latest, “Poor Things,” is a phantasmagorical “Frankenstein”-like tale of a baby experiencing the world in a grown woman’s body. Source
Emma Stone, director Yorgos Lanthimos on “Poor Things”
Emma Stone, the Oscar-winning star of “La La Land,” and Yorgos Lanthimos, director of such acclaimed films as “The Lobster” and “The Favourite,” have teamed up on several projects, including “Poor Things,” a phantasmagorical “Frankenstein”-like tale of a baby experiencing the world in a grown woman’s body. And there are more Stone-Lanthimos films on the way. Correspondent Tracy Smith talks with the two who appear, professionally, to be joined at the hip. Source
Behind the Houthis’ missile, drone attacks on shipping in the Red Sea
The Houthis, an armed political and religious group in Yemen with close ties to Iran, have cast themselves on social media as champions of the besieged people of Gaza, and are deploying Iranian-supplied weapons to disrupt global commerce and take on the U.S. military. CBS News national security correspondent David Martin explains why Hamas’ incursion into Israel on October 7 has led the Houthis to widen the war over Gaza. Source
Ancient earthen structures in Ohio become a UNESCO World Heritage Site
Scattered throughout Central Ohio are earthworks that are believed to have been constructed by ancient indigenous people for ceremonial or spiritual purposes up to two thousand years ago. Several, including some burial mounds, are protected as part of Hopewell Culture National Historical Park. And now, they have been designated a UNESCO World Heritage Site. Correspondent Conor Knighton explores the grandeur of these mysterious complexes. Source
How Ozempic, other weight-loss drugs are “changing medicine”
Ozempic and other GLP-1 class medications are being proven beneficial for reducing cardiovascular risk and treating diabetes. But they also signal fullness to the brain and regulate blood sugar, allowing people to lose on average 10 to 20 percent of their body weight in the first year. For many of the roughly 74 percent of Americans who are overweight or obese, that’s almost unimaginable. Correspondent Susan Spencer talks with doctors and patients about how these drugs work, and why they are considered life-changing (and even, for Wall Street analysts, a miracle). Source